[go: up one dir, main page]

AU8295587A - Nasal solutions - Google Patents

Nasal solutions

Info

Publication number
AU8295587A
AU8295587A AU82955/87A AU8295587A AU8295587A AU 8295587 A AU8295587 A AU 8295587A AU 82955/87 A AU82955/87 A AU 82955/87A AU 8295587 A AU8295587 A AU 8295587A AU 8295587 A AU8295587 A AU 8295587A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
human calcitonin
nasal solutions
meterable
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU82955/87A
Other versions
AU608268B2 (en
Inventor
Leo Geller
Peter Glanzmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU8295587A publication Critical patent/AU8295587A/en
Application granted granted Critical
Publication of AU608268B2 publication Critical patent/AU608268B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions in the form of aqueous solutions for the nasal administration of human calcitonin in meterable amounts, a process for the production of these pharmaceutical compositions and their use are described. The pharmaceutical composition contains a) a therapeutically effective amount of human calcitonin or a derivative thereof, b) viscosity-increasing swelling agents and c) an aqueous vehicle optionally containing isotonic additives and/or additional auxiliaries.
AU82955/87A 1986-12-23 1987-12-22 Nasal solutions Ceased AU608268B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH5200/86 1986-12-23
CH520086 1986-12-23

Publications (2)

Publication Number Publication Date
AU8295587A true AU8295587A (en) 1988-06-23
AU608268B2 AU608268B2 (en) 1991-03-28

Family

ID=4289609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82955/87A Ceased AU608268B2 (en) 1986-12-23 1987-12-22 Nasal solutions

Country Status (15)

Country Link
EP (1) EP0277462B1 (en)
JP (1) JPS63166832A (en)
AT (1) ATE75404T1 (en)
AU (1) AU608268B2 (en)
CA (1) CA1322330C (en)
DE (1) DE3778682D1 (en)
DK (1) DK166714B1 (en)
ES (1) ES2032303T3 (en)
GR (1) GR3004585T3 (en)
IL (1) IL84861A (en)
MY (1) MY102411A (en)
NZ (1) NZ223005A (en)
PH (1) PH24802A (en)
PT (1) PT86436B (en)
ZA (1) ZA879593B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015246A1 (en) * 1990-04-10 1991-10-17 The University Of Melbourne Calcitonin gene related peptide for the treatment of undescended testicles
AU638128B2 (en) * 1990-04-10 1993-06-17 University Of Melbourne, The Calcitonin gene related peptide for the treatment of undescended testicles

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
JP3179538B2 (en) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト Aqueous solution of stable human calcitonin
GB9108634D0 (en) * 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
EP0803255A4 (en) * 1994-06-03 1999-06-30 Tsumura & Co Medicinal composition
WO1999038492A1 (en) * 1998-01-30 1999-08-05 Novartis Consumer Health S.A. Nasal solutions
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026073A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
JP2002154989A (en) * 2000-11-14 2002-05-28 Lion Corp Ophthalmic composition and composition for improving retention of drug on living mucosa
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
CH657858A5 (en) * 1983-06-27 1986-09-30 Ciba Geigy Ag SUBSTANCE FROM THE CALCITONINE GROUP.
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
DE3500268A1 (en) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt PREPARATIONS WITH DELAYED EFFECT, METHOD FOR THE PRODUCTION THEREOF AND CORRESPONDING AGENTS FOR THE HUMAN OR. VETERINE MEDICAL APPLICATION
JPS61194034A (en) * 1985-02-25 1986-08-28 Teijin Ltd Powdery composition for transnasal administration

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015246A1 (en) * 1990-04-10 1991-10-17 The University Of Melbourne Calcitonin gene related peptide for the treatment of undescended testicles
AU638128B2 (en) * 1990-04-10 1993-06-17 University Of Melbourne, The Calcitonin gene related peptide for the treatment of undescended testicles

Also Published As

Publication number Publication date
ES2032303T3 (en) 1993-02-01
PT86436B (en) 1990-11-20
NZ223005A (en) 1990-07-26
CA1322330C (en) 1993-09-21
IL84861A (en) 1992-09-06
PT86436A (en) 1988-01-01
DK676987A (en) 1988-06-24
AU608268B2 (en) 1991-03-28
DK166714B1 (en) 1993-07-05
PH24802A (en) 1990-10-30
ATE75404T1 (en) 1992-05-15
JPS63166832A (en) 1988-07-11
DE3778682D1 (en) 1992-06-04
MY102411A (en) 1992-06-17
EP0277462A1 (en) 1988-08-10
ZA879593B (en) 1988-06-22
GR3004585T3 (en) 1993-04-28
DK676987D0 (en) 1987-12-22
EP0277462B1 (en) 1992-04-29

Similar Documents

Publication Publication Date Title
DE3875025D1 (en) COMPOSITION CONTAINING CALCITONIN FOR NASAL ADMINISTRATION.
MY101026A (en) An improved method for administering insulin.
EP0552256A4 (en)
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
MY101784A (en) Novel pharmacological compounds
AU8295587A (en) Nasal solutions
AU581442B2 (en) 2-substituted-1, 3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
IL78061A (en) Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane
EP0153152A3 (en) (2-oxo-1,2,3,5-tetrahydroimidazo-/2,1-b/quinnazolinyl)-oxyalkylamides, their preparation, compositions containing them and their use in making medicaments
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
CA2095352A1 (en) Compositions containing psyllium
JPS5551019A (en) Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
GR3004113T3 (en)
IT8722647A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
IL88737A (en) Aqueous pharmaceutical dithranol formulations for topical use
DK277387A (en) THERAPEUTIC TOPICAL COMPOSITION AGAINST A HYPERPROLIFIING EPITHAL DISEASE
ATE36957T1 (en) N,N-DIETHYL-5-METHYL-2H,1-BENZOTHIOPYRANO-(4,3,-CD)-INDAZOLE-2-ETHANAMINE, THE PREPARATIONS CONTAINING THEM AND THEIR USE.
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
IL76458A0 (en) Polyether ionophore,its preparation and pharmaceutical and veterinary preparations containing it
EP0354042A3 (en) Aminobenzoic-acid derivatives to reduce side effects induced by an administration of immuno-suppressant
ES2029161A6 (en) Process for the preparation of zinc carbocysteinate compositions and their use in hepatopathies.
JO1531B1 (en) Novel pharmacological compounds